EPS Diluted (Annual) Chart

View EPS Diluted (Annual) for ANGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Annual) Chart
Start Trial

Historical EPS Diluted (Annual) Data

View and export this data back to 2000. Start Trial.
Date Value
May 31, 2026 -0.8848
May 31, 2025 -0.8321
May 31, 2024 -4.588
May 31, 2023 -1.328
May 31, 2022 -0.6805
May 31, 2021 -0.8228
May 31, 2020 -4.394
May 31, 2019 0.4094
May 31, 2018 0.4406
May 31, 2017 0.14
May 31, 2016 -1.21
May 31, 2015 -0.09
May 31, 2014 0.08
May 31, 2013 -0.02
Date Value
May 31, 2012 -0.20
May 31, 2011 0.32
May 31, 2010 0.50
May 31, 2009 0.41
May 31, 2008 0.45
May 31, 2007 -0.49
May 31, 2006 0.53
May 31, 2005 0.37
May 31, 2004 0.32
May 31, 2003 0.11
May 31, 2002 0.11
May 31, 2001 0.04
May 31, 2000 -0.15

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Annual) Range, Past 5 Years

View EPS Diluted (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Annual) Benchmarks

View EPS Diluted (Annual) Benchmarks
Start Trial
Boston Scientific Corp. 1.939
Penumbra, Inc. 4.522
Abbott Laboratories 3.718
Alphatec Holdings, Inc. -0.9553
AtriCure, Inc. -0.2398